This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Gilead Sciences, Inc., Gilead Calistoga LLC. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Seattle, WA (US) (2013 - 2015)
- Minneapolis, MN (US) (2016 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: The Innovative Mind of Lafe J. Purvis, II: Advancements in PI3K Inhibitors
Introduction: Lafe J. Purvis, II is an accomplished inventor based in Seattle, WA, whose work has led to the development of significant advancements in pharmaceutical sciences. With a total of six patents to his name, Purvis has made noteworthy contributions to the field, particularly in the area of phosphatidylinositol 3-kinase (PI3K) inhibitors, which have profound implications for various medical conditions.
Latest Patents: Purvis's latest patents focus on phosphatidylinositol 3-kinase inhibitors. The first patent discloses specific inhibitors of PI3K, or pharmaceutically acceptable salts thereof, identified by the formula (J). These compounds are particularly useful for treating conditions mediated by one or more PI3K isoforms. Additionally, it outlines pharmaceutical compositions that include these compounds and describes methods for their use. Another significant patent also centers around PI3K inhibitors represented by formula (I), showcasing their utility in the treatment of conditions involving PI3K isoforms.
Career Highlights: Lafe J. Purvis, II has a noteworthy career marked by his contributions to major pharmaceutical companies, including Gilead Sciences, Inc. and Gilead Calistoga LLC. His work has been pivotal in advancing the understanding and treatment of diseases linked to PI3K pathways.
Collaborations: Throughout his career, Purvis has collaborated with esteemed colleagues such as Musong Kim and Joshua A. Kaplan. These partnerships have been instrumental in enhancing the research and development processes in the projects they undertook together.
Conclusion: Lafe J. Purvis, II exemplifies the essence of innovation in the pharmaceutical industry with his continuous efforts to develop effective treatments through his patented inventions. His work on phosphatidylinositol 3-kinase inhibitors not only demonstrates his expertise as an inventor but also his commitment to improving health outcomes through scientific research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile